Compare CVS Health Corp (CVS) vs JPMorgan Diversified Return International Eqty ETF (JPIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs JPMorgan Diversified Return International Eqty ETF — how do they compare? CVS Health Corp trades at $93.7 (market cap $119.58B), while JPMorgan Diversified Return International Eqty ETF trades at $76.97. The key difference: CVS Health Corp pays a 2.84% dividend while JPMorgan Diversified Return International Eqty ETF pays none, and JPMorgan Diversified Return International Eqty ETF is trading nearer its 52-week high, CVS Health Corp nearer its low. Which is the better fit depends on your goals.
| CVS | JPIN | |
|---|---|---|
Market Cap | $119.58B | — |
Sector | Health | — |
52-Week High | $110.60 | $77.00 |
52-Week Low | $65.51 | $64.96 |
Enterprise Value | $181.93B | — |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.
The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.
JPIN, the JPMorgan Diversified Return International Equity ETF, trades at $76.97, up 0.8% on the day, with a bullish technical signal driven by moving averages. The ETF provides broad exposure to foreign large-cap value stocks. Key technical indicators show overbought conditions with RSI levels above 74, while the ADX indicates a strong trend. A dividend of $0.91 per share is scheduled for payment in June 2026.
The outlook for JPIN is supported by its smart beta strategy targeting international value equities, though overbought technicals suggest near-term consolidation risk. Investment appeal lies in diversified global exposure, but risks include currency fluctuations and international market volatility. The absence of current fundamental data limits valuation assessment, requiring reliance on technical and sentiment indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About JPMorgan Diversified Return International Eqty ETF
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →
